The Protective Effects of S14G-humanin (HNG) Against Lipopolysaccharide (LPS)- Induced Inflammatory Response in Human Dental Pulp Cells (hDPCs) Mediated by the TLR4/MyD88/NF-κB Pathway
Overview
Authors
Affiliations
Pulpitis is reported in large populations of patients and significantly impacts their normal life quality. It is reported that the lipopolysaccharide (LPS) in Gram-negative bacteria induces severe inflammation in dental pulp tissues. S14G-humanin is a derivative of humanin and has been recently confirmed to possess promising anti-inflammatory properties. The current study aims to explore the possibility of treating pulpitis with S14G-humanin. LPS-stimulated dental pulp cells (DPCs) were utilized to simulate an inflammatory state in the progression of pulpitis. We found the elevated expressions and production of interleukin- 6 (IL-6), tumor necrosis factor-α (TNF-α), macrophage chemoattractant protein-1 (MCP-1), matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9), upregulated Pentraxin 3 (PTX3) and activated oxidative stress in LPS-treated DPCs were all reversed by treatment with 50 and 100 μM S14G-humanin. In addition, the LPS-induced elevated expression levels of toll-like receptor 4 (TLR4) and myeloid differentiation primary response 88 (Myd88), and activation of the IκBα/NF-κB signaling pathway in hDPCs were significantly repressed by treatment with S14G-humanin. Conclusively, we found that S14G-humanin protected LPS-treated hDPCs by inhibiting the TLR4/MyD88/NF-κB signaling pathway.
Zhang Y, Huang X, Luo Y, Ma X, Luo L, Liang L J Nanobiotechnology. 2024; 22(1):537.
PMID: 39227963 PMC: 11373145. DOI: 10.1186/s12951-024-02810-z.
S14G-humanin alleviates acute lung injury by inhibiting the activation of NF-κB.
Wu Y, Zhang H, Guan L, Jia X, Wang M Aging (Albany NY). 2023; 15(23):13865-13875.
PMID: 38054825 PMC: 10756097. DOI: 10.18632/aging.205267.
Su B, Li R, Song F, Liu M, Sun X Aging (Albany NY). 2023; 15(14):6822-6833.
PMID: 37451839 PMC: 10415557. DOI: 10.18632/aging.204874.
Glucocorticoid induced bone disorders in children: Research progress in treatment mechanisms.
Hua J, Huang J, Li G, Lin S, Cui L Front Endocrinol (Lausanne). 2023; 14:1119427.
PMID: 37082116 PMC: 10111257. DOI: 10.3389/fendo.2023.1119427.
Liang C, Wu W, He X, Xue F, Feng D J Dent Sci. 2023; 18(1):191-202.
PMID: 36643232 PMC: 9831794. DOI: 10.1016/j.jds.2022.06.012.